My career is focused on steering innovations towards a clinical or research use-case. Translating the voice-of-the-customer into product requirements, agnostic to a specific technology, is one #usercentered approach to objectively assess whether a new biomedical technology has current or future value for a user. I've been fortunate to have held roles that blend strategy development and execution in the development of innovative technologies. I've also executed partnerships leveraging resources towards a shared goal and authored several articles on opportunities and challenges of public-private-partnerships. My career has supported the missions of: a global health philanthropy (Bill and Melinda Gates Foundation), a biomedical research think-tank (FasterCures, a center of the Milken Institute), and two federal funding agencies (National Cancer Institute and DARPA). I also serve as a voting member of a scientific advisory board for a multi-pharmaceutical public private partnership (Quebec Consortium for Drug Discovery), serve as a technical reviewer for the European Commission, and provide ad-hoc advice to several rare-disease patient philanthropies that are actively funding research. My technical background includes biospecimen policy work as a AAAS Science and Technology Policy Fellow at the NCI and bench research developing cancer nanotechnologies at UCSF and UC Berkeley, with a foundation in inorganic chemistry.
Listed skills include Science, Chemistry, Research, Hplc, and 24 others.